Invitrogen Corporation Release: Life Technologies Corporation's Solutions Enable Tissue-Engineered Transplant

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, announced today that GIBCO cell culture media products were used in an experimental procedure to replace the trachea of a woman whose lung had collapsed. The procedure was reported in the November 19, 2008 issue of Lancet, in an article by Macchiarini, et al, entitled “Clinical transplantation of a tissue-engineered airway.”